Oncology Intelligence Digest • October 2, 2026 Oncology Intelligence Digest October 2, 2026 Five weeks after the FDA’s August 26, 2026 approval of Revolution Medicines’… Pro Hub Membership Required You must be a Pro Hub member to access this content. Join Now Already a member? Log in here